Melius Research Upgrades Xylem to Buy, Announces $122 Price Target
Portfolio Pulse from Benzinga Newsdesk
Melius Research analyst Scott Davis has upgraded Xylem (NYSE:XYL) from Hold to Buy and announced a price target of $122.
October 02, 2023 | 11:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xylem's stock has been upgraded to Buy from Hold by Melius Research, with a price target set at $122.
The upgrade from Hold to Buy by Melius Research indicates a positive outlook for Xylem. The price target of $122 suggests that the analyst believes the stock has significant upside potential. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100